Video
Succeeding with Innovation: State of Radioligand Therapy Readiness in Europe
Dec 14, 2023
Radioligand therapy (RLT) is emerging as an essential pillar in cancer care. It is a targeted treatment approach that has shown clinical benefits in treating gastroenteropancreatic neuroendocrine tumors and advanced prostate cancer. It is also being researched as a promising treatment modality for several other advanced cancers. The scientific innovation in radioligand therapies is progressing rapidly; however, the healthcare system readiness for this treatment modality is lagging. There is a critical and urgent need to enhance the understanding of the current level of readiness for RLT across countries and to address issues impacting this in order to ensure patient access in a timely and equitable manner.
Video
Succeeding with Innovation: State of Radioligand Therapy Readiness in Europe

Related solutions

Contact Us